A Post-Marketing Observational Study to Document Treatment Patterns and to Evaluate Leuprolide and Alternative Therapeutic Approaches to the Treatment of Advanced Prostate Cancer
A Post-Marketing Observational Study to Document Treatment Patterns and to Evaluate Leuprolide and Alternative Therapeutic Approaches to the Treatment of Advanced Prostate Cancer
Document treatment patterns and evaluate LUCRIN / LUCRIN-TRIDEPOT® (Leuprolide) and alternative therapeutic approaches to the treatment of advanced prostate cancer during normal clinical practice and in accordance with the terms of the Belgian marketing authorization and reimbursement conditions.
Inclusion Criteria:
Exclusion Criteria:
Genk-Waterschei, B-3600, Belgium
Gouy-Les-Pietons, B-6181, Belgium
Leper, B-8900, Belgium
Leper, B-8900, Belgium
Lesves, B-1380, Belgium
Roeslare, B-8800, Belgium
Saint Truiden, B-3800, Belgium